You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Esophageal Neoplasms

Showing 51 - 75 of 4,187
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Cancer Trial (Adjuvant Immunoradiotherapy (ARM1) and Adjuvant Immunotherapy (ARM1B), Adjuvant chemoradiotherapy)

Not yet recruiting
  • Esophageal Cancer
  • Adjuvant Immunoradiotherapy (ARM1) and Adjuvant Immunotherapy (ARM1B)
  • Adjuvant chemoradiotherapy
  • (no location specified)
Dec 19, 2022

Public's Intended Uptake and Views on Organization of Esophageal

Not yet recruiting
  • Barrett Esophagus
  • +2 more
  • Survey
  • (no location specified)
Jan 10, 2023

Esophageal Tumors Trial (radiation, drug, biological)

Not yet recruiting
  • Esophageal Neoplasms
  • Radiation
  • +2 more
  • (no location specified)
Oct 16, 2023

Esophageal Cancer Trial (Tislelizumab, Radiation, Paclitaxel)

Not yet recruiting
  • Esophageal Cancer
  • (no location specified)
Nov 18, 2022

Sintilimab and Anlotinib in Combination With Chemo Trial in Xi'an (Sintilimab and anlotinib in combination with chemo)

Completed
  • Sintilimab and Anlotinib in Combination With Chemotherapy
  • Sintilimab and anlotinib in combination with chemotherapy
  • Xi'an, Shanxi, China
  • +1 more
Aug 27, 2023

Esophageal Cancer, Radiation Therapy, Immunotherapy Trial in Taizhou (Toripalimab, Tegafur, IMRT)

Recruiting
  • Esophageal Cancer
  • +3 more
  • Taizhou, Zhejiang, China
  • +1 more
Apr 15, 2023

Cancer of Stomach, Cancer of the Esophagus, Drug Use Trial in Stockholm (Proton pump inhibitor)

Completed
  • Cancer of Stomach
  • +2 more
  • Proton pump inhibitor
  • Stockholm, Please Select (US/Canada Only)..., Sweden
    Karolinska Institutet, Department of Molecular Medicine and Surg
Jan 9, 2023

Nivolumab in Treatment of Early Stage Esophageal or

Not yet recruiting
  • Esophageal Carcinoma
  • Gastroesophageal Junction Carcinoma
    • Louisville, Kentucky
    • +2 more
    Mar 21, 2023

    A Multicenter, Cross-sectional Study on Quality of Life in

    Not yet recruiting
    • Assessing the Current Quality of Life Status of Esophageal Cancer Patients Who Have Undergone Radical Chemoradiotherapy/Radiotherapy and Long-term Survival
    • questionnaire investigation
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute & Hospital
    Apr 24, 2023

    ERAS Protocol in RAME for Esophageal Cancer

    Completed
    • Esophageal Cancer Patients
    • ERAS protocol
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 31, 2022

    Lung Cancer, Esophageal Cancer Trial in Philadelphia (Pulsed Low Dose Radiation, Carboplatin, Paclitaxel)

    Recruiting
    • Lung Cancer
    • Esophageal Cancer
    • Pulsed Low Dose Radiation
    • +2 more
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Dec 2, 2022

    Esophageal Cancer Risk Registry

    Recruiting
    • Esophageal Cancer
    • +4 more
    • Survey of client health, personal habits, family history
    • +3 more
    • Pittsburgh, Pennsylvania
      Department of Cardiothoracic Surgery
    Jan 23, 2023

    Esophageal Cancer Trial in Saint Louis

    Completed
    • Esophageal Cancer
      • Saint Louis, Missouri
        Washington University School of Medicine
      Aug 8, 2022

      Stomach Tumors, Esophageal Tumors Trial in Japan (Amivantamab)

      Recruiting
      • Stomach Neoplasms
      • Esophageal Neoplasms
      • Chuo-Ku, Japan
      • +10 more
      Jan 27, 2023

      Esophageal Cancer Trial in Weihui, Suining, Beijing (Utidelone and anlotinib)

      Recruiting
      • Esophageal Cancer
      • Utidelone and anlotinib
      • Weihui, Henan, China
      • +2 more
      May 10, 2023

      Esophageal Cancer Trial in Tianjin (Arm A, Arm B)

      Not yet recruiting
      • Esophageal Cancer
      • Arm A
      • Arm B
      • Tianjin, Tianjin, China
        Tianjin Cancer Hospital
      Sep 24, 2023

      Esophageal Cancer Trial (cushion)

      Not yet recruiting
      • Esophageal Cancer
      • cushion
      • (no location specified)
      Sep 13, 2022

      Esophageal cAncer Screening Trial

      Completed
      • Esophageal Squamous Cell Carcinoma
      • +2 more
      • Sponge cytological test
      • Shanghai, Shanghai, China
        Changhai Hospital
      Sep 17, 2022

      Primary Tumor Burden Score:A Novel Staging Parameter for ESCC

      Completed
      • Neoplasm, Esophagus
      • Neoplasm, Squamous Cell
      • nCRT
      • (no location specified)
      Apr 20, 2023

      Esophageal Cancer Surgery Trial in Milan (Prehabilitation)

      Recruiting
      • Esophageal Cancer Surgery
      • Prehabilitation
      • Milan, MI, Italy
        IRCCS San Raffaele Scientific Institute
      Dec 23, 2022

      Small Cell Lung Cancer, Immunotherapy Trial in Changsha (chronic psychological stress)

      Recruiting
      • Small Cell Lung Cancer
      • Immunotherapy
      • chronic psychological stress
      • Changsha, Hunan, China
        Department of Oncology, The Second Xiangya Hospital, Central Sou
      Jul 22, 2023

      Esophageal Cancer in Northeastern Iran

      Active, not recruiting
      • Esophageal Cancer
      • GI Disease
        • Tehran, Iran, Islamic Republic of
          Digestive Disease Research Institute
        Aug 18, 2022

        Gross Tumor Delineation of Esophageal Cancer on MR, CT and PET

        Active, not recruiting
        • Esophageal Cancer
        • MR, PET CT
        • Ljubljana, Slovenia
          Institute of Oncology
        Nov 3, 2022

        Gastric Polyp, Gastric Tumor, Duodenal Tumors Trial in Be'er Ya'aqov (Tranexamic acid, Epinephrine injection)

        Not yet recruiting
        • Gastric Polyp
        • +3 more
        • Tranexamic acid
        • Epinephrine injection
        • Be'er Ya'aqov, Israel
          Shamir Medical Center
        Jan 8, 2023

        Esophagus Cancer Trial in Xiamen (Tislelizumab, Paclitaxel-albumin, Carboplatin)

        Recruiting
        • Esophagus Cancer
        • Xiamen, Fujian, China
          ShanghaiZhongshan
        Apr 8, 2023